The newest weight loss drug on the market, Zepbound, might also help keep people’s snoring down. On Wednesday, Eli Lilly announced the preliminary results of two Phase III trials testing its drug tirzepatide for people with both obesity and obstructive sleep apnea . Not only did those taking the drug lose much more weight than those on placebo, they also breathed easier at night and experienced substantially fewer episodes of sleep apnea .
Eli Lilly ran two Phase III studies of people living with obesity and moderate-to-severe obstructive sleep apnea for 52 weeks each. Both studies were placebo-controlled and randomized, but in one trial, participants were also taking positive airway pressure therapy, a standard treatment for sleep apnea.
Obesity Apnea Obesity Drug Central Sleep Apnea Anti-Obesity Medication Health Medical Pharma Tirzepatide Novo Nordisk Eli Lilly Sleep And Weight Obstructive Sleep Apnea Snoring Tirzepatide Semaglutide Jeff Emmick Sleep Disorders Gizmodo
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Arkansas Childhood Obesity Rates Increase Despite Obesity Letters to ParentsSince Arkansas started sending the obesity letters to parents, the state's childhood obesity rates rose to nearly 24% from 21%. During the pandemic, the state obesity rate hit a high of more than 26%.
Source: KPBSnews - 🏆 240. / 63 Read more »
Prior Anti-Obesity Drug Use Curbs Weight Loss on SemaglutidePatients who were overweight or obese lost more weight taking semaglutide if they hadn't previously taken another anti-obesity medication.
Source: Medscape - 🏆 386. / 55 Read more »
Effect of Prior Anti-Obesity Drug Use on Weight Loss Outcomes of Semaglutide InjectionsA retrospective study evaluated the impact of prior anti-obesity drug use on the weight loss outcomes of weekly semaglutide injections in patients with overweight or obesity. The study found heterogeneous results and aimed to determine the difference in weight loss percentage between patients with and without prior anti-obesity treatment.
Source: Medscape - 🏆 386. / 55 Read more »
Medicare Plans May Now Provide Limited Coverage For Obesity Drug WegovyI'm an independent healthcare analyst with more than 25 years of experience analyzing, publishing and presenting/educating on healthcare policy and pharmaceuticals. I have 114 publications in peer-reviewed journals, in addition to more than 450 articles in periodicals and newspapers. I have also presented my work at numerous conferences.
Source: ForbesTech - 🏆 318. / 59 Read more »
Scientists discover fat genes that dramatically increase risk of obesityResearchers hope they can develop a drug to combat obesity.
Source: KJNBNews - 🏆 526. / 51 Read more »
Evening Exercise Proves Superior in New Obesity StudyScience, Space and Technology News 2024
Source: SciTechDaily1 - 🏆 84. / 68 Read more »